Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis.
The link between multiple sclerosis and depression.
Adaptive personalized training games for individual and collaborative rehabilitation of people with multiple sclerosis.
Distinct roles of T-cell lymphopenia and the microbial flora for gastrointestinal and CNS autoimmunity.
Treating prolactinoma can prevent autoimmune diseases.
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.
Platelets and vascular inflammation of the brain.
Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis.
Impact of high intensity exercise on muscle morphology in EAE rats.
Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
Neurobiology: Myelin Goes Where the Action Is.
Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?
Beneficial effect of a multimerized immunoglobulin Fc in an animal model of inflammatory neuropathy (experimental autoimmune neuritis).
Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a.
NG2-glia and their functions in the central nervous system.
Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.
Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis.
Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS.
Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.
GABAergic Agonists Modulate the Glutamate Release from Frontal Cortex Synaptosomes of Rats with Experimental Autoimmune Encephalomyelitis.
[Chemical constituents from roots of Illicium majus].
[Criteria of ineffectiveness of treatment with first-line therapy: how to use MRI results in decision making?]
Protein-based classifier to predict conversion from clinically isolated syndrome to multiple sclerosis.
Oral corticosteroids for multiple sclerosis relapse.
Pages
« first
‹ previous
…
480
481
482
483
484
485
486
487
488
…
next ›
last »